Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Time to Sell?

Shares of Merck KGaA (OTCMKTS:MKGAF) gapped down prior to trading on Tuesday . The stock had previously closed at $166.6010, but opened at $153.48. Merck KGaA shares last traded at $154.00, with a volume of 50 shares.

Merck KGaA Trading Up 2.9%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm’s fifty day moving average is $163.02 and its two-hundred day moving average is $149.53. The firm has a market cap of $20.62 billion, a P/E ratio of 24.36 and a beta of 0.96.

Hedge Funds Weigh In On Merck KGaA

A number of institutional investors have recently bought and sold shares of the stock. Elefante Mark B bought a new stake in Merck KGaA during the 2nd quarter valued at approximately $617,000. Ames National Corp bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $1,009,000. Notis McConarty Edward purchased a new stake in Merck KGaA in the second quarter worth $1,304,000. North Star Asset Management Inc. bought a new position in Merck KGaA in the second quarter worth $1,411,000. Finally, Pinnacle Holdings LLC bought a new position in Merck KGaA in the second quarter worth $1,487,000. 0.10% of the stock is owned by institutional investors.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.